Literature DB >> 15097

Tyrosine hydroxylase: delayed activation in central noradrenergic neurons and induction in adrenal medulla elicited by stimulation of central cholinergic receptors.

T Lewander, T H Joh, D J Reis.   

Abstract

The centrally active muscarinic agonist, oxotremorine, elicited an up to 2-fold dose-dependent (0.25-1.5 mg/kg) increase in the activity of tyrosine hydroxylase (TH) in the rat nucleus locus coeruleus (LC) and adrenal medulla. The response occurred in LC after 24 to 48 hours and in adrenal medulla by 4 to 8 hours, peaked in LC at 72 hours and adrenal medulla at 16 to 24 hours and persisted up to 2 weeks in both tissues. In brain the effect appeared confined to cell bodies of noradrenergic neurons. The activity of dopamine beta-hydroxylase increased in adrenal medulla (40%) but not in brain. Immunotitration with anti-TH serum demonstrated that the increase of TH activity in LC is due to increased catalytic activity (activation), whereas in adrenal medulla it is due to a transynaptically mediated accumulation of enzyme protein (induction). Physostigmine (1.0 mg/kg), pilocarpine (25-50 mg/kg) and nicotine (10 mg/kg) increased TH activity in LC and adrenal. We conclude that stimulation of central cholinergic receptors of the muscarinic type results in a delayed and protracted activaiton of TH but not of dopamine beta-hydroxylase in cell bodies of central noradrenergic neurons, and reflexly, to transynaptic induction of TH and dopamine beta-hydroxylase in the adrenal medulla.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 15097

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  9 in total

1.  Direct phosphorylation of brain tyrosine hydroxylase by cyclic AMP-dependent protein kinase: mechanism of enzyme activation.

Authors:  T H Joh; D H Park; D J Reis
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

2.  Translation of tyrosine hydroxylase from poly(A)-mRNA in pheochromocytoma cells is enhanced by dexamethasone.

Authors:  E E Baetge; B B Kaplan; D J Reis; T H Joh
Journal:  Proc Natl Acad Sci U S A       Date:  1981-02       Impact factor: 11.205

3.  Further evidence for, and nature of, the facilitatory GABAergic influence on central noradrenergic transmission.

Authors:  T Dennis; O Curet; T Nishikawa; B Scatton
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-11       Impact factor: 3.000

4.  Anaesthetic and forebrain modulation of raphe-coerulean interactions.

Authors:  A McRae-Degueurce; C M Sinton
Journal:  Exp Brain Res       Date:  1984       Impact factor: 1.972

Review 5.  Tyrosine hydroxylase regulation in the central nervous system.

Authors:  J M Masserano; N Weiner
Journal:  Mol Cell Biochem       Date:  1983       Impact factor: 3.396

6.  Effects of subacute administration of methamphetamine and nicotine on locomotor activity in transgenic mice expressing the human tyrosine hydroxylase gene.

Authors:  T Nabeshima; A Itoh; K Kobayashi; S Morita; T Mizuguchi; H Sawada; A Nitta; T Hasegawa; K Hayashi; T Nagatsu
Journal:  J Neural Transm Gen Sect       Date:  1994

7.  Brain catecholamines modifications. The effects on memory facilitation induced by oxotremorine in mice.

Authors:  P Huygens; C M Baratti; J L Gardella; E Filinger
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

8.  Co-release of noradrenaline and dopamine in the cerebral cortex elicited by single train and repeated train stimulation of the locus coeruleus.

Authors:  Paola Devoto; Giovanna Flore; Pierluigi Saba; Mauro Fà; Gian Luigi Gessa
Journal:  BMC Neurosci       Date:  2005-05-02       Impact factor: 3.288

9.  Insights into the mechanism by which atropine inhibits myopia: evidence against cholinergic hyperactivity and modulation of dopamine release.

Authors:  Kate Thomson; Tamsin Kelly; Cindy Karouta; Ian Morgan; Regan Ashby
Journal:  Br J Pharmacol       Date:  2021-10-10       Impact factor: 9.473

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.